MUVON Therapeutics
PrivateLast Round
Grant
Dec 12, 2025
Total Funding Raised
$22.42M
Company Overview
MUVON Therapeutics is a biotechnology company developing a cell therapy platform for the regeneration of skeletal muscle tissue using a patient's own cells, with an initial focus on treating stress urinary incontinence in women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B2C
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MUVON Therapeutics Comparables
Compare MUVON Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovacell Inc | 88% | |
| Cook Group Incorporated | 83% | |
| Versameb AG | 74% | |
MUVON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2025 | ||||
| Series A | May 31, 2021 | ||||
| Accelerator | Apr 1, 2021 |
Key People
Founding team and executive leadership
MUVON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wyss Zurich | Series A, Accelerator |
| Innosuisse | Grant |
| University of Zurich | Series A |
| Lichtsteiner Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors increased 89% MoM, reaching 3.5K.
- Nov 8, 2025
Monthly visitors grew 280% MoM, reaching 1.8K.
MUVON Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MUVON Therapeutics's valuation, stock price, and market status.